West Pharmaceutical Services (WST) Return on Invested Capital (2016 - 2025)
Historic Return on Invested Capital for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to 0.14%.
- West Pharmaceutical Services' Return on Invested Capital fell 200.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.15% for FY2025, which is 100.0% down from last year.
- Latest data reveals that West Pharmaceutical Services reported Return on Invested Capital of 0.14% as of Q4 2025, which was down 200.0% from 0.15% recorded in Q3 2025.
- In the past 5 years, West Pharmaceutical Services' Return on Invested Capital registered a high of 0.26% during Q1 2022, and its lowest value of 0.14% during Q4 2025.
- Over the past 5 years, West Pharmaceutical Services' median Return on Invested Capital value was 0.18% (recorded in 2023), while the average stood at 0.2%.
- Its Return on Invested Capital has fluctuated over the past 5 years, first skyrocketed by 900bps in 2021, then tumbled by -700bps in 2023.
- West Pharmaceutical Services' Return on Invested Capital (Quarter) stood at 0.26% in 2021, then dropped by -14bps to 0.22% in 2022, then decreased by -17bps to 0.18% in 2023, then fell by -12bps to 0.16% in 2024, then dropped by -12bps to 0.14% in 2025.
- Its Return on Invested Capital stands at 0.14% for Q4 2025, versus 0.15% for Q3 2025 and 0.15% for Q2 2025.